PROSTAMAX
Also known as Prostamax, prostate bioregulator, Ala-Glu-Asp-Leu
PROSTAMAX is a peptide bioregulator from Khavinson's series specifically targeting prostatic epithelial cells. It is a tissue-specific tetrapeptide designed to normalize the functional activity of prostate cells, support healthy prostate tissue, and address benign prostatic hyperplasia (BPH). Long-term studies in Russia show reduced BPH symptoms and improved urinary flow.
How it works
Tissue-specific tetrapeptide that penetrates prostatic epithelial cell nuclei and interacts with chromatin, normalizing gene expression in prostate tissue. Reduces cellular hyperproliferation, modulates androgen receptor signaling, and promotes healthy apoptosis in dysregulated cells.
Benefits
- Normalizes prostate cell function and promotes healthy tissue renewal
- Reduces symptoms of benign prostatic hyperplasia (BPH)
- Improves urinary flow and reduces frequency
- Anti-inflammatory effects on prostatic tissue
- May reduce PSA levels in BPH
- Supports sexual function via prostate health
- Epigenetic restoration of prostatic cell gene expression
Dosing
100–500 mcg · Once daily
Typical course: 100–500mcg/day SubQ or IM for 10–30 days. Course-based — not chronic daily use. Repeat 1–2x yearly.
Ranges reflect commonly cited research protocols, not a prescription. Dose with a licensed provider.
Reconstitution
25mg vial with 2–5mL BAC water. Use within 30 days refrigerated.
Helix’s free reconstitution calculator gives you the exact draw volume → get the app
Common stacks
Reported side effects
- Generally well tolerated
- Injection site irritation
- Very limited data outside Russian clinical trials
Who it’s for
Men over 40 with BPH symptoms, elevated PSA, or prostate health concerns. Men seeking preventive prostate aging support.
Track PROSTAMAX in Helix
Dose reminders, reconstitution math, vial tracking, and AI guidance — free on iOS.
Download free